Viewing Study NCT03480750


Ignite Creation Date: 2025-12-24 @ 5:03 PM
Ignite Modification Date: 2026-03-04 @ 12:10 AM
Study NCT ID: NCT03480750
Status: COMPLETED
Last Update Posted: 2020-11-10
First Post: 2018-03-02
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Trial of Trientine Plus Pegylated Liposomal Doxorubicin and Carboplatin in Epithelial Ovarian Cancer
Sponsor: National Cheng-Kung University Hospital
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-09
Start Date Type: ACTUAL
Primary Completion Date: 2015-10
Primary Completion Date Type: ACTUAL
Completion Date: 2019-12
Completion Date Type: ACTUAL
First Submit Date: 2018-03-02
First Submit QC Date: None
Study First Post Date: 2018-03-29
Study First Post Date Type: ACTUAL
Results First Submit Date: 2020-02-29
Results First Submit QC Date: None
Results First Post Date: 2020-11-10
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-10-18
Last Update Post Date: 2020-11-10
Last Update Post Date Type: ACTUAL